NASDAQ:TKNO Alpha Teknova (TKNO) Stock Price, News & Analysis $7.34 -0.02 (-0.27%) Closing price 04:00 PM EasternExtended Trading$7.28 -0.06 (-0.82%) As of 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Alpha Teknova Stock (NASDAQ:TKNO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Alpha Teknova alerts:Sign Up Key Stats Today's Range$7.05▼$7.3850-Day Range$4.61▼$7.3952-Week Range$1.91▼$7.84Volume180,058 shsAverage Volume270,287 shsMarket Capitalization$393.50 millionP/E RatioN/ADividend YieldN/APrice Target$7.50Consensus RatingHold Company Overview Alpha Teknova, Inc. (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications. The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations. Alpha Teknova also provides process development and scale-up manufacturing services for clients seeking tailored reagents or contract production, enabling seamless transition from bench-scale research to commercial-scale manufacturing. Headquartered in Hollister, California, Alpha Teknova serves a global customer base with sales and distribution channels across North America, Europe and Asia. Founded to streamline and enhance life science research, the company’s management team combines deep expertise in research, product development and commercial operations, positioning Alpha Teknova to address evolving needs in the biotechnology and pharmaceutical sectors.AI Generated. May Contain Errors. Read More Alpha Teknova Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks34th Percentile Overall ScoreTKNO MarketRank™: Alpha Teknova scored higher than 34% of companies evaluated by MarketBeat, and ranked 717th out of 917 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingHold Consensus RatingAlpha Teknova has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.Upside/DownsideThe consensus price target for Alpha Teknova is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageAlpha Teknova has only been the subject of 4 research reports in the past 90 days.Read more about Alpha Teknova's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Alpha Teknova are expected to grow in the coming year, from ($0.28) to ($0.23) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alpha Teknova is -23.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alpha Teknova is -23.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAlpha Teknova has a P/B Ratio of 5.73. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Alpha Teknova's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.21% of the float of Alpha Teknova has been sold short.Short Interest Ratio / Days to CoverAlpha Teknova has a short interest ratio ("days to cover") of 16.99, which indicates bearish sentiment.Change versus previous monthShort interest in Alpha Teknova has recently decreased by 5.27%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAlpha Teknova does not currently pay a dividend.Dividend GrowthAlpha Teknova does not have a long track record of dividend growth. News and Social Media3.6 / 5News Sentiment0.78 News SentimentAlpha Teknova has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Alpha Teknova this week, compared to 2 articles on an average week.Search Interest4 people have searched for TKNO on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows1 people have added Alpha Teknova to their MarketBeat watchlist in the last 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Alpha Teknova insiders have not sold or bought any company stock.Percentage Held by Insiders13.20% of the stock of Alpha Teknova is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions13.81% of the stock of Alpha Teknova is held by institutions.Read more about Alpha Teknova's insider trading history. Receive TKNO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alpha Teknova and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TKNO Stock News HeadlinesAlpha Teknova: Ample Manufacturing Capacity At A High PremiumAugust 24 at 9:19 AM | seekingalpha.comAlpha Teknova (TKNO) Stock Moves Higher on Booming Clinical DemandAugust 7, 2026 | insidermonkey.comSilicon Valley Insider: "Forget AI Stocks"A 25-year Silicon Valley veteran who recommended Nvidia before its 32,000 percent run says the next wave of AI gains wont come from Nvidia, Tesla, or SpaceX. He points to a detail buried on page 37 of the SpaceX IPO filing, tied to Elon Musks plans for 1 million AI satellites, 1 billion humanoid robots, and 200 billion AI chips a year. He says one overlooked sector could benefit most from this spending, and has identified a company trading under $1 that may factor into Musks supply chain.August 24 at 1:00 AM | Brownstone Research (Ad)Teknova targets less than $8M 2026 free cash outflow as it lifts revenue guide to $45M-$47MAugust 6, 2026 | seekingalpha.comTeknova Launches Build-Tek™, a Proprietary AI Reagent Assistant That Allows Customers to Configure Complex Custom Product Requests in MinutesAugust 5, 2026 | markets.businessinsider.comTeknova Reports Second Quarter 2026 Financial ResultsAugust 5, 2026 | globenewswire.comTeknova to Report Second Quarter 2026 Financial Results on August 5, 2026July 22, 2026 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO), Arcus Biosciences (RCUS) and Tenaya Therapeutics (TNYA)June 4, 2026 | theglobeandmail.comSee More Headlines TKNO Stock Analysis - Frequently Asked Questions How have TKNO shares performed this year? Alpha Teknova's stock was trading at $3.80 on January 1st, 2026. Since then, TKNO shares have increased by 93.2% and is now trading at $7.34. How were Alpha Teknova's earnings last quarter? Alpha Teknova, Inc. (NASDAQ:TKNO) announced its quarterly earnings data on Wednesday, August, 5th. The company reported ($0.06) earnings per share for the quarter, beating analysts' consensus estimates of ($0.08) by $0.02. The firm earned $12.19 million during the quarter, compared to the consensus estimate of $10.95 million. Alpha Teknova had a negative trailing twelve-month return on equity of 24.94% and a negative net margin of 38.37%. Read the conference call transcript. When did Alpha Teknova IPO? Alpha Teknova (TKNO) raised $90 million in an IPO on Thursday, June 24th 2021. The company issued 6,000,000 shares at a price of $14.00-$16.00 per share. Who are Alpha Teknova's major shareholders? Top institutional investors of Alpha Teknova include BlackRock Inc. (1.64%), Bank of America Corp DE (0.48%), Bank of New York Mellon Corp (0.20%) and GSA Capital Partners LLP (0.10%). Insiders that own company stock include Telegraph Hill Partners Iv, L, J Matthew Mackowski, Stephen Gunstream, Matthew Lowell, Damon Terrill, Ken Gelhaus and Martha J Demski. View institutional ownership trends. How do I buy shares of Alpha Teknova? Shares of TKNO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Alpha Teknova own? Based on aggregate information from My MarketBeat watchlists, some other companies that Alpha Teknova investors own include Myomo (MYO), Heron Therapeutics (HRTX), Taboola.com (TBLA), Ultralife (ULBI), NVIDIA (NVDA) and Sensus Healthcare (SRTS). Company Calendar Last Earnings8/05/2026Today8/24/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 TKNO's financial health is in the Green zone, according to TradeSmith. TKNO has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:TKNO CIK1850902 Webwww.teknova.com Phone831-637-1100FaxN/AEmployees240Year Founded1996Price Target and Rating Average Price Target for Alpha Teknova$7.50 High Price Target$8.00 Low Price Target$7.00 Potential Upside/Downside+2.2%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($0.31) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$17.26 million Net Margins-38.37% Pretax Margin-38.16% Return on Equity-24.94% Return on Assets-16.53% Debt Debt-to-Equity Ratio0.21 Current Ratio4.49 Quick Ratio3.48 Sales & Book Value Annual Sales$40.52 million Price / Sales9.71 Cash FlowN/A Price / Cash FlowN/A Book Value$1.28 per share Price / Book5.73Miscellaneous Outstanding Shares53,610,000Free Float46,537,000Market Cap$393.50 million OptionableNot Optionable Beta0.64 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:TKNO) was last updated on 8/24/2026 by MarketBeat.com Staff. From Our PartnersIn 2022, every resident of this state received $3,284Since 1982, Alaska has paid every resident an annual check from its oil wealth, $3,284 in 2022 alone, funded e...Freedom Financial | SponsoredI found Rolls-Royce at $2 - now I see the same setup againIn 2022, Karim Rahemtulla recommended Rolls-Royce under $2 - a misunderstood aerospace name the market had wri...Monument Traders Alliance | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredBuy These Stocks Before August 31stKeith Kaplan has invested $17 million into his own AI research platform, now used by 180,000 investors worldwi...TradeSmith | SponsoredThe dollar just brokeBloomberg research shows the U.S. dollar's share of global reserves has fallen to the lowest level this centur...Porter & Company | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Teknova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Teknova With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
